Alan Korman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alan korman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alan Korman Today - Breaking & Trending Today

Sanofi's $125 million Israeli drug buy could be a three-pronged cancer buster


Workers in the Biond Biologics lab in Misgav, Israel (Courtesy)
The anti-cancer drug developed by Biond Biologics, which the Israeli startup will now try on humans in clinical trials with France-based multinational Sanofi, takes a multipronged approach to fighting tumors, activating three kind of cells in the immune system at the same time.
Paris-based multinational pharma firm Sanofi signed a licensing agreement earlier this month for Biond’s flagship anti-tumor drug BND-22, a cancer immunotherapy medication.
Under the terms of the agreement, Biond will receive an upfront payment of $125 million in cash and up to $1 billion in potential development, regulatory and sales milestones, as well as tiered double-digit royalty payments, the Israeli firm said in a statement. Biond will lead the first-in-human Phase 1a clinical trial of the drug, evaluating its safety and tolerability. Afterwards, Sanofi will take on development responsibilities and commercialization of the ....

France General , Alan Korman , Redhill Biopharma , Itay Friedman , Jeff Weber , Biond Biologics , Bristol Myers Squibb , Tehila Ben Moshe , Langone Medical Center , Drug Administration , Perlmutter Cancer Center , Ori Shilo , Immuno Oncology Discovery , Design Cells , Getty Images , Investigational New Drug , பிரான்ஸ் ஜநரல் , ஆலன் கோர்மன் , அது ப்ரைட்மேன் , ஜெஃப் வெபர் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , தெஹிலா பென் மோஷ் , லன்கொனே மருத்துவ மையம் , பேர்ல்முத்தேர் புற்றுநோய் மையம் , ஓரி ஷிலோ , இம்யூனோ புற்றுநோயியல் கண்டுபிடிப்பு ,